サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/04/30 | 1,290 | 1,380 | 1,266 | 1,340 | +87 | +6.9% | 1,466,900 |
2020/04/28 | 1,222 | 1,259 | 1,222 | 1,253 | +21 | +1.7% | 498,200 |
2020/04/27 | 1,234 | 1,244 | 1,214 | 1,232 | +17 | +1.4% | 495,400 |
2020/04/24 | 1,208 | 1,251 | 1,185 | 1,215 | -1 | -0.1% | 629,900 |
2020/04/23 | 1,158 | 1,254 | 1,158 | 1,216 | +75 | +6.6% | 1,050,200 |
2020/04/22 | 1,182 | 1,198 | 1,136 | 1,141 | -58 | -4.8% | 807,600 |
2020/04/21 | 1,265 | 1,316 | 1,190 | 1,199 | -80 | -6.3% | 1,271,500 |
2020/04/20 | 1,439 | 1,439 | 1,250 | 1,279 | -207 | -13.9% | 3,080,300 |
2020/04/17 | 1,474 | 1,507 | 1,466 | 1,486 | +36 | +2.5% | 679,500 |
2020/04/16 | 1,445 | 1,498 | 1,421 | 1,450 | +8 | +0.6% | 787,200 |
2020/04/15 | 1,525 | 1,534 | 1,435 | 1,442 | -103 | -6.7% | 1,007,700 |
2020/04/14 | 1,557 | 1,616 | 1,480 | 1,545 | -43 | -2.7% | 1,708,900 |
2020/04/13 | 1,355 | 1,624 | 1,319 | 1,588 | +249 | +18.6% | 2,016,900 |
2020/04/10 | 1,291 | 1,341 | 1,270 | 1,339 | +59 | +4.6% | 544,000 |
2020/04/09 | 1,253 | 1,297 | 1,230 | 1,280 | +31 | +2.5% | 549,500 |
2020/04/08 | 1,220 | 1,249 | 1,178 | 1,249 | +47 | +3.9% | 511,500 |
2020/04/07 | 1,209 | 1,238 | 1,170 | 1,202 | +44 | +3.8% | 554,000 |
2020/04/06 | 1,143 | 1,161 | 1,090 | 1,158 | ±0 | ±0% | 503,300 |
2020/04/03 | 1,235 | 1,235 | 1,144 | 1,158 | -39 | -3.3% | 376,700 |
2020/04/02 | 1,191 | 1,250 | 1,191 | 1,197 | +5 | +0.4% | 547,500 |
2020/04/01 | 1,199 | 1,266 | 1,177 | 1,192 | +32 | +2.8% | 959,300 |
2020/03/31 | 1,197 | 1,208 | 1,145 | 1,160 | -22 | -1.9% | 612,400 |
2020/03/30 | 1,156 | 1,288 | 1,150 | 1,182 | -3 | -0.3% | 802,200 |
2020/03/27 | 1,226 | 1,244 | 1,156 | 1,185 | -6 | -0.5% | 595,400 |
2020/03/26 | 1,203 | 1,280 | 1,186 | 1,191 | -89 | -7% | 564,700 |
2020/03/25 | 1,254 | 1,290 | 1,184 | 1,280 | +146 | +12.9% | 731,100 |
2020/03/24 | 1,068 | 1,210 | 1,060 | 1,134 | +108 | +10.5% | 954,700 |
2020/03/23 | 1,008 | 1,077 | 1,002 | 1,026 | -12 | -1.2% | 831,100 |
2020/03/19 | 1,250 | 1,275 | 963 | 1,038 | -201 | -16.2% | 1,927,000 |
2020/03/18 | 1,286 | 1,361 | 1,235 | 1,239 | -22 | -1.7% | 806,600 |
2020/03/17 | 1,192 | 1,297 | 1,179 | 1,261 | -63 | -4.8% | 1,258,500 |
2020/03/16 | 1,276 | 1,432 | 1,252 | 1,324 | +86 | +6.9% | 820,600 |
2020/03/13 | 1,225 | 1,288 | 1,162 | 1,238 | -137 | -10% | 1,178,800 |
2020/03/12 | 1,394 | 1,474 | 1,351 | 1,375 | -79 | -5.4% | 784,800 |
2020/03/11 | 1,505 | 1,561 | 1,451 | 1,454 | -70 | -4.6% | 453,700 |
2020/03/10 | 1,313 | 1,540 | 1,313 | 1,524 | +46 | +3.1% | 1,099,600 |
2020/03/09 | 1,601 | 1,605 | 1,458 | 1,478 | -196 | -11.7% | 1,036,600 |
2020/03/06 | 1,705 | 1,722 | 1,666 | 1,674 | -53 | -3.1% | 618,200 |
2020/03/05 | 1,805 | 1,821 | 1,702 | 1,727 | -58 | -3.2% | 852,800 |
2020/03/04 | 1,742 | 1,840 | 1,718 | 1,785 | +43 | +2.5% | 606,000 |
2020/03/03 | 1,889 | 1,898 | 1,738 | 1,742 | -60 | -3.3% | 809,000 |
2020/03/02 | 1,652 | 1,849 | 1,651 | 1,802 | +116 | +6.9% | 1,037,100 |
2020/02/28 | 1,702 | 1,793 | 1,651 | 1,686 | -135 | -7.4% | 1,405,800 |
2020/02/27 | 1,890 | 1,908 | 1,800 | 1,821 | -79 | -4.2% | 889,800 |
2020/02/26 | 1,961 | 1,982 | 1,866 | 1,900 | -86 | -4.3% | 974,800 |
2020/02/25 | 1,919 | 2,001 | 1,919 | 1,986 | -63 | -3.1% | 838,800 |
2020/02/21 | 2,050 | 2,076 | 2,034 | 2,049 | -22 | -1.1% | 477,100 |
2020/02/20 | 2,150 | 2,156 | 2,069 | 2,071 | -54 | -2.5% | 576,200 |
2020/02/19 | 2,080 | 2,132 | 2,076 | 2,125 | +69 | +3.4% | 794,300 |
2020/02/18 | 2,130 | 2,165 | 2,011 | 2,056 | -101 | -4.7% | 1,327,300 |
1301~
1350
件表示中 / 2536件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 253,000円 | - | - | 0.00% | - | 117.18倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 152,500円 | +5.0% | +1.5% | 0.00% | 13.05倍 | 3.67倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
科研薬 | 388,200円 | -6.4% | -71.8% | 4.89% | 43.23倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 304,000円 | +7.9% | -3.3% | 2.63% | 8.46倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム